Category: US Stock
If upstream margins improve, project execution is strong, and new energy / low carbon investments begin contributing...
Wingstop (WING) has posted explosive growth — 36.8% system sales jump in 2024, and Q1 net income surged 221% — but rising costs...
TGoPro Inc. (NASDAQ: GPRO) has recently experienced a notable uptick in its stock price, closing at $1.72 on September 8, 2025...
Tesla delivered mixed Q2 results—production was resilient, but deliveries lagged. Profitability stabilized but margin...
Tesla delivered mixed Q2 results—production was resilient, but deliveries lagged. Profitability stabilized but margin...
Adagene is a clinical-stage biopharma firm developing antibody-based immunotherapies with proprietary platforms that optimize...
Abercrombie & Fitch continues to deliver strong topline growth and brand momentum, particularly via its Hollister platform...
Coya Therapeutics (Nasdaq: COYA) represents a high-risk, high-reward biotech play: minimal revenue, consistent losses, but...
Anebulo is a high-conviction, early-stage biotech play centered on a first-in-class pediatric cannabis intoxication antidote...
Connect Biopharma is transitioning from clinical-stage uncertainty to regulatory readiness and commercial preparation. With a...
Anebulo Pharmaceuticals is executing on a clear, high-impact strategy—developing an IV cannabis antidote for children—while...
CNTB upcoming rademikibart data updates and China approval pathway are critical triggers that could dramatically shift its...
Our Clients Reviews
Read what our clients have to say about their experience with EWNation.
